Literature DB >> 11110501

Mydriasis and glaucoma: exploding the myth. A systematic review.

R J Pandit1, R Taylor.   

Abstract

AIMS: To investigate the risk of inducing acute glaucoma following mydriasis.
METHODS: Systematic review of published research 1933-1999.
RESULTS: The risk of inducing acute glaucoma following mydriasis with tropicamide alone is close to zero, no case being identified. The risk with long-acting or combined agents is between 1 in 3,380 and 1 in 20,000. The presence of chronic glaucoma constitutes no additional risk.
CONCLUSIONS: Mydriasis with tropicamide alone is safe even in people with chronic glaucoma. It should be advised in all patients when thorough retinal examination is indicated.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11110501     DOI: 10.1046/j.1464-5491.2000.00368.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  27 in total

Review 1.  Non-steroidal drug-induced glaucoma.

Authors:  M R Razeghinejad; M J Pro; L J Katz
Journal:  Eye (Lond)       Date:  2011-06-03       Impact factor: 3.775

2.  'Non-steroidal drug-induced glaucoma' by MR Razeghinejad, MJ Pro and LJ Katz.

Authors:  P K Wishart
Journal:  Eye (Lond)       Date:  2011-12-02       Impact factor: 3.775

3.  Anterior segment changes after pharmacologic mydriasis using Pentacam and optical coherence tomography in angle closure suspects.

Authors:  Jing-Min Guo; Mu Li; Xiao-Lan Xu; Hong Zhang; Jun-Ming Wang
Journal:  Int J Ophthalmol       Date:  2015-10-18       Impact factor: 1.779

4.  Fundoscopy: to dilate or not to dilate?

Authors:  Gerald Liew; Paul Mitchell; Jie Jin Wang; Tien Yin Wong
Journal:  BMJ       Date:  2006-01-07

5.  Direct ophthalmoscopic examination of the eyes: does a mydriatic agent help with diagnosis?

Authors:  A M Carlsson; M W ten Hove; F Stockl
Journal:  Can Fam Physician       Date:  2006-08       Impact factor: 3.275

6.  Smart phone ophthalmoscopy: a potential replacement for the direct ophthalmoscope.

Authors:  Sunil Mamtora; Maria Teresa Sandinha; Amritha Ajith; Anna Song; David H W Steel
Journal:  Eye (Lond)       Date:  2018-07-24       Impact factor: 3.775

7.  The modulation of fragile X behaviors by the muscarinic M4 antagonist, tropicamide.

Authors:  Surabi Veeraragavan; Nghiem Bui; Jennie R Perkins; Lisa A Yuva-Paylor; Richard Paylor
Journal:  Behav Neurosci       Date:  2011-10       Impact factor: 1.912

8.  Telemedicine and Diabetic Retinopathy: Review of Published Screening Programs.

Authors:  Kevin Tozer; Maria A Woodward; Paula A Newman-Casey
Journal:  J Endocrinol Diabetes       Date:  2015-11-11

9.  Characterizing Current Attitudes and Practices for Human Subject Safety in Studies Involving Pupil Dilation.

Authors:  Jacob Szpernal; Joseph Carroll; Ryan Spellecy; Jane A Bachman Groth
Journal:  J Empir Res Hum Res Ethics       Date:  2020-11-02       Impact factor: 1.742

Review 10.  Clinical Components of Telemedicine Programs for Diabetic Retinopathy.

Authors:  Mark B Horton; Paolo S Silva; Jerry D Cavallerano; Lloyd Paul Aiello
Journal:  Curr Diab Rep       Date:  2016-12       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.